Literature DB >> 24878127

Comparison of 30-day and 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients aged≤50 years (the Coronary aRtery diseAse in younG adultS Study).

Fausto Biancari1, Tomas Gudbjartsson2, Jouni Heikkinen3, Vesa Anttila3, Timo Mäkikallio4, Anders Jeppsson5, Linda Thimour-Bergström5, Carmelo Mignosa6, Antonino S Rubino6, Kari Kuttila7, Jarmo Gunn7, Jan-Ola Wistbacka8, Kari Teittinen9, Kari Korpilahti10, Francesco Onorati11, Giuseppe Faggian11, Giulia Vinco12, Corrado Vassanelli12, Flavio Ribichini12, Tatu Juvonen3, Tomas A Axelsson2, Axel F Sigurdsson13, Pasi P Karjalainen14, Ari Mennander15, Olli Kajander15, Markku Eskola15, Erkki Ilveskoski15, Veronica D'Oria16, Marisa De Feo16, Tuomas Kiviniemi7, K E Juhani Airaksinen7.   

Abstract

Data on the outcome of young patients after coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are scarce. Data on 2,209 consecutive patients aged≤50 years who underwent CABG or PCI were retrospectively collected from 15 European institutions. PCI and CABG had similar 30-day mortality rates (0.8% vs 1.4%, p=0.27), late survival (at 5 years, 97.8% vs 94.9%, p=0.082), and freedom from stroke (at 5 years, 98.0% and 98.0%, p=0.731). PCI was associated with significantly lower freedom from major adverse cardiac and cerebrovascular events (at 5 years, 73.9% vs 85.0%, p<0.0001), repeat revascularization (at 5 years, 77.6% vs 92.5%, p<0.0001), and myocardial infarction (at 5 years, 89.9% vs 96.6%, p<0.0001) compared with CABG. These findings were confirmed in propensity score-adjusted and matched analyses. Freedom from major adverse cardiac and cerebrovascular events after PCI was particularly low in diabetics (at 5 years, 58.0% vs 75.9%, p<0.0001) and in patients with multivessel disease (at 5 years, 63.6% vs 85.1%, p<0.0001). PCI in patients with ST elevation myocardial infarction was associated with significantly better 5-year survival (97.5% vs 88.8%, p=0.001), which was driven by its lower 30-day mortality rate (1.5% vs 6.0%, p=0.017). In conclusion, patients aged≤50 years have an excellent immediate outcome after either PCI or CABG with similar long-term survival when used according to the current clinical practice. PCI was associated with significantly lower freedom from myocardial infarction and repeat revascularization.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24878127     DOI: 10.1016/j.amjcard.2014.04.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Vascular Disease in Young Indians (20-40 years): Role of Ischemic Heart Disease.

Authors:  Jamshed Dalal; Murugesh Shantaveeraya Hiremath; Mrinal Kanti Das; Devangkumar M Desai; Vijay Kumar Chopra; Arup Das Biswas
Journal:  J Clin Diagn Res       Date:  2016-09-01

Review 2.  Does Age Affect the Short- and Long-Term Outcomes of Coronary Bypass Grafting?

Authors:  Pavan Ashwini Anand; Suresh Keshavamurthy; Ellis M Shelley; Sibu Saha
Journal:  Int J Angiol       Date:  2021-08-25

Review 3.  Newer perspectives of coronary artery disease in young.

Authors:  Amitesh Aggarwal; Saurabh Srivastava; M Velmurugan
Journal:  World J Cardiol       Date:  2016-12-26

4.  The Impact of Age on Clinical Outcomes of Coronary Artery Bypass Grafting: Long-Term Results of a Real-World Registry.

Authors:  Francesco Nicolini; Daniela Fortuna; Giovanni Andrea Contini; Davide Pacini; Davide Gabbieri; Claudio Zussa; Rossana De Palma; Antonella Vezzani; Tiziano Gherli
Journal:  Biomed Res Int       Date:  2017-12-20       Impact factor: 3.411

5.  Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients Aged 18-45 Years with Diabetes Mellitus.

Authors:  Yang Li; Ran Dong; Kun Hua; Tao-Shuai Liu; Shao-You Zhou; Ning Zhou; Hong-Jia Zhang
Journal:  Chin Med J (Engl)       Date:  2017-12-20       Impact factor: 2.628

6.  Trends in Characteristics and Outcomes of Hospitalized Young Patients Undergoing Coronary Artery Bypass Grafting in the United States, 2004 to 2018.

Authors:  Sourbha S Dani; Abdul Mannan Khan Minhas; Adeel Arshad; Troy Krupica; Sachin S Goel; Salim S Virani; Garima Sharma; Ron Blankstein; Michael J Blaha; Sadeer G Al-Kindi; Khurram Nasir; Safi U Khan
Journal:  J Am Heart Assoc       Date:  2021-08-28       Impact factor: 5.501

7.  Late Myocardial Infarction and Repeat Revascularization after Coronary Artery Bypass Grafting in Patients with Prior Percutaneous Coronary Intervention.

Authors:  Fausto Biancari; Antonio Salsano; Francesco Santini; Marisa De Feo; Magnus Dalén; Qiyao Zhang; Giuseppe Gatti; Enzo Mazzaro; Ilaria Franzese; Ciro Bancone; Marco Zanobini; Tuomas Tauriainen; Timo Mäkikallio; Matteo Saccocci; Alessandra Francica; Stefano Rosato; Zein El-Dean; Francesco Onorati; Giovanni Mariscalco
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

8.  Serum VEGF Predicts Worse Clinical Outcome of Patients with Coronary Heart Disease After Percutaneous Coronary Intervention Therapy.

Authors:  Xia Han; Lili Liu; Jiamin Niu; Jun Yang; Zengtang Zhang; Zhiqiang Zhang
Journal:  Med Sci Monit       Date:  2015-10-26

9.  Intermediate-Term Risk of Stroke Following Cardiac Procedures in a Nationally Representative Data Set.

Authors:  Laura Stein; Alison Thaler; John W Liang; Stanley Tuhrim; Amit S Dhamoon; Mandip S Dhamoon
Journal:  J Am Heart Assoc       Date:  2017-12-02       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.